Published in Mol Cell Biol on August 01, 1997
Yeast carbon catabolite repression. Microbiol Mol Biol Rev (1998) 5.91
Molecular genetics of the RNA polymerase II general transcriptional machinery. Microbiol Mol Biol Rev (1998) 4.49
A human RNA polymerase II complex containing factors that modify chromatin structure. Mol Cell Biol (1998) 3.45
Mammalian mediator of transcriptional regulation and its possible role as an end-point of signal transduction pathways. Proc Natl Acad Sci U S A (1998) 3.18
The Med proteins of yeast and their function through the RNA polymerase II carboxy-terminal domain. Genes Dev (1998) 2.91
An activator binding module of yeast RNA polymerase II holoenzyme. Mol Cell Biol (1999) 2.00
Interplay of positive and negative regulators in transcription initiation by RNA polymerase II holoenzyme. Mol Cell Biol (1998) 1.69
Mediator protein mutations that selectively abolish activated transcription. Proc Natl Acad Sci U S A (1999) 1.65
Requirement for a functional interaction between mediator components Med6 and Srb4 in RNA polymerase II transcription. Mol Cell Biol (1998) 1.48
Activator-specific requirement of yeast mediator proteins for RNA polymerase II transcriptional activation. Mol Cell Biol (1999) 1.44
A multiplicity of mediators: alternative forms of transcription complexes communicate with transcriptional regulators. Nucleic Acids Res (1997) 1.31
RNA polymerase subunit RPB5 plays a role in transcriptional activation. Proc Natl Acad Sci U S A (1998) 1.10
Analysis of Schizosaccharomyces pombe mediator reveals a set of essential subunits conserved between yeast and metazoan cells. Proc Natl Acad Sci U S A (2001) 1.04
Loss of the Rpb4/Rpb7 subcomplex in a mutant form of the Rpb6 subunit shared by RNA polymerases I, II, and III. Mol Cell Biol (2003) 1.03
Transcriptional regulation: contending with complexity. Proc Natl Acad Sci U S A (1999) 1.03
Independent recruitment of mediator and SAGA by the activator Met4. Mol Cell Biol (2006) 1.01
The Med1 subunit of the yeast mediator complex is involved in both transcriptional activation and repression. Proc Natl Acad Sci U S A (1999) 0.97
Topoisomerase III is required for accurate DNA replication and chromosome segregation in Schizosaccharomyces pombe. Nucleic Acids Res (2002) 0.85
Drosophila Med6 is required for elevated expression of a large but distinct set of developmentally regulated genes. Mol Cell Biol (2001) 0.81
Role for human mediator subunit MED25 in recruitment of mediator to promoters by endoplasmic reticulum stress-responsive transcription factor ATF6α. J Biol Chem (2013) 0.79
Basic local alignment search tool. J Mol Biol (1990) 659.07
CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res (1994) 392.47
A system of shuttle vectors and yeast host strains designed for efficient manipulation of DNA in Saccharomyces cerevisiae. Genetics (1989) 105.30
A multiprotein mediator of transcriptional activation and its interaction with the C-terminal repeat domain of RNA polymerase II. Cell (1994) 8.44
A rapid method for localized mutagenesis of yeast genes. Yeast (1992) 7.79
Direct and selective binding of an acidic transcriptional activation domain to the TATA-box factor TFIID. Nature (1990) 7.11
An RNA polymerase II holoenzyme responsive to activators. Nature (1994) 6.22
Structure of a yeast pheromone gene (MF alpha): a putative alpha-factor precursor contains four tandem copies of mature alpha-factor. Cell (1982) 5.64
A multisubunit complex associated with the RNA polymerase II CTD and TATA-binding protein in yeast. Cell (1993) 5.35
A kinase-cyclin pair in the RNA polymerase II holoenzyme. Nature (1995) 4.93
RNA polymerase II holoenzyme contains SWI/SNF regulators involved in chromatin remodeling. Cell (1996) 4.03
Reduced binding of TFIID to transcriptionally compromised mutants of VP16. Nature (1991) 3.98
The TATA-binding protein is required for transcription by all three nuclear RNA polymerases in yeast cells. Cell (1992) 3.94
A novel mediator between activator proteins and the RNA polymerase II transcription apparatus. Cell (1990) 3.74
TAFs mediate transcriptional activation and promoter selectivity. Trends Biochem Sci (1996) 3.59
A human RNA polymerase II complex associated with SRB and DNA-repair proteins. Nature (1996) 3.50
Binding of basal transcription factor TFIIH to the acidic activation domains of VP16 and p53. Mol Cell Biol (1994) 3.46
TBP-associated factors are not generally required for transcriptional activation in yeast. Nature (1996) 3.45
Activation of class II gene transcription by regulatory factors is potentiated by a novel activity. Cell (1991) 3.36
Distinguishing between mechanisms of eukaryotic transcriptional activation with bacteriophage T7 RNA polymerase. Cell (1987) 3.26
Transcription activation in cells lacking TAFIIS. Nature (1996) 3.04
Intragenic and extragenic suppressors of mutations in the heptapeptide repeat domain of Saccharomyces cerevisiae RNA polymerase II. Genetics (1989) 3.04
A mediator required for activation of RNA polymerase II transcription in vitro. Nature (1991) 3.00
Yeast global transcriptional regulators Sin4 and Rgr1 are components of mediator complex/RNA polymerase II holoenzyme. Proc Natl Acad Sci U S A (1995) 2.96
Interaction between an acidic activator and transcription factor TFIIB is required for transcriptional activation. Nature (1993) 2.88
General requirement for RNA polymerase II holoenzymes in vivo. Proc Natl Acad Sci U S A (1995) 2.88
Transcription. A growing coactivator network. Nature (1996) 2.71
Association of an activator with an RNA polymerase II holoenzyme. Genes Dev (1995) 2.61
KIN28 encodes a C-terminal domain kinase that controls mRNA transcription in Saccharomyces cerevisiae but lacks cyclin-dependent kinase-activating kinase (CAK) activity. Mol Cell Biol (1995) 2.49
TBP-TAF complexes: selectivity factors for eukaryotic transcription. Curr Opin Cell Biol (1994) 2.46
A mammalian RNA polymerase II holoenzyme containing all components required for promoter-specific transcription initiation. Cell (1995) 2.41
GAL11 protein, an auxiliary transcription activator for genes encoding galactose-metabolizing enzymes in Saccharomyces cerevisiae. Mol Cell Biol (1988) 2.41
Involvement of the SIN4 global transcriptional regulator in the chromatin structure of Saccharomyces cerevisiae. Mol Cell Biol (1992) 2.39
Characterization of physical interactions of the putative transcriptional adaptor, ADA2, with acidic activation domains and TATA-binding protein. J Biol Chem (1995) 2.37
A mammalian SRB protein associated with an RNA polymerase II holoenzyme. Nature (1996) 2.16
ADA3, a putative transcriptional adaptor, consists of two separable domains and interacts with ADA2 and GCN5 in a trimeric complex. Mol Cell Biol (1995) 2.11
Accurate initiation at RNA polymerase II promoters in extracts from Saccharomyces cerevisiae. Proc Natl Acad Sci U S A (1987) 2.10
The Saccharomyces cerevisiae SPT13/GAL11 gene has both positive and negative regulatory roles in transcription. Mol Cell Biol (1989) 2.09
Human TAFII 105 is a cell type-specific TFIID subunit related to hTAFII130. Cell (1996) 1.96
Genetic and physical interactions between yeast RGR1 and SIN4 in chromatin organization and transcriptional regulation. Genetics (1995) 1.92
Contacts in context: promoter specificity and macromolecular interactions in transcription. Cell (1996) 1.80
Mediator of transcriptional regulation. Trends Biochem Sci (1996) 1.78
Yeast Gal11 protein mediates the transcriptional activation signal of two different transacting factors, Gal4 and general regulatory factor I/repressor/activator site binding protein 1/translation upstream factor. Proc Natl Acad Sci U S A (1990) 1.74
Yeast TAF(II)90 is required for cell-cycle progression through G2/M but not for general transcription activation. Genes Dev (1996) 1.72
The human general co-factors. Trends Biochem Sci (1996) 1.70
Regulation of HIS4 expression by the Saccharomyces cerevisiae SIN4 transcriptional regulator. Genetics (1995) 1.69
Activation of the TFIID-TFIIA complex with HMG-2. Genes Dev (1995) 1.66
Yeast HMG proteins NHP6A/B potentiate promoter-specific transcriptional activation in vivo and assembly of preinitiation complexes in vitro. Genes Dev (1996) 1.66
Yeast SUB1 is a suppressor of TFIIB mutations and has homology to the human co-activator PC4. EMBO J (1996) 1.49
The coactivator p15 (PC4) initiates transcriptional activation during TFIIA-TFIID-promoter complex formation. EMBO J (1995) 1.46
The yeast TFB1 and SSL1 genes, which encode subunits of transcription factor IIH, are required for nucleotide excision repair and RNA polymerase II transcription. Mol Cell Biol (1995) 1.38
A yeast transcriptional stimulatory protein similar to human PC4. J Biol Chem (1996) 1.27
Isolation and characterization of mutants which show an oversecretion phenotype in Saccharomyces cerevisiae. Genetics (1988) 1.02
Prevention of fat-induced insulin resistance by salicylate. J Clin Invest (2001) 4.74
A multisubunit complex containing the SWI1/ADR6, SWI2/SNF2, SWI3, SNF5, and SNF6 gene products isolated from yeast. Proc Natl Acad Sci U S A (1994) 4.21
Biosynthetic response of cartilage explants to dynamic compression. J Orthop Res (1989) 2.98
Yeast global transcriptional regulators Sin4 and Rgr1 are components of mediator complex/RNA polymerase II holoenzyme. Proc Natl Acad Sci U S A (1995) 2.96
Idiopathic transverse myelitis: MR characteristics. AJNR Am J Neuroradiol (1996) 2.48
Inducible T cell antigen 4-1BB. Analysis of expression and function. J Immunol (1993) 2.40
Double-blind evaluation of subthalamic nucleus deep brain stimulation in advanced Parkinson's disease. Neurology (1998) 2.19
Protocol issues for delayed Gd(DTPA)(2-)-enhanced MRI (dGEMRIC) for clinical evaluation of articular cartilage. Magn Reson Med (2001) 2.13
A newly identified member of the tumor necrosis factor receptor superfamily with a wide tissue distribution and involvement in lymphocyte activation. J Biol Chem (1997) 2.00
Mediator, not holoenzyme, is directly recruited to the heat shock promoter by HSF upon heat shock. Mol Cell (2001) 2.00
An activator binding module of yeast RNA polymerase II holoenzyme. Mol Cell Biol (1999) 2.00
Association of a microRNA-323b polymorphism with the persistence of hepatitis B virus infection by the enhancement of viral replication. J Viral Hepat (2013) 1.98
Overexpression of Pto activates defense responses and confers broad resistance. Plant Cell (1999) 1.81
The Cdc42 GTPase-associated proteins Gic1 and Gic2 are required for polarized cell growth in Saccharomyces cerevisiae. Genes Dev (1997) 1.79
Mediator of transcriptional regulation. Trends Biochem Sci (1996) 1.78
Sex education and its association with teenage sexual activity, pregnancy and contraceptive use. Fam Plann Perspect (1982) 1.74
The structural and functional organization of the yeast mediator complex. J Biol Chem (2001) 1.71
N-Cadherin extracellular repeat 4 mediates epithelial to mesenchymal transition and increased motility. J Cell Biol (2000) 1.65
Signals through 4-1BB are costimulatory to previously activated splenic T cells and inhibit activation-induced cell death. J Immunol (1997) 1.62
Platelet-derived growth factor-induced H(2)O(2) production requires the activation of phosphatidylinositol 3-kinase. J Biol Chem (2000) 1.62
An increase in cancer stem cell population after primary systemic therapy is a poor prognostic factor in breast cancer. Br J Cancer (2011) 1.62
Mechanisms for maternal age differences in birth weight. Am J Epidemiol (1995) 1.61
In vivo requirement of activator-specific binding targets of mediator. Mol Cell Biol (2000) 1.58
4-1BB T-cell antigen binds to mature B cells and macrophages, and costimulates anti-mu-primed splenic B cells. Eur J Immunol (1994) 1.58
Exposure to air pollution during different gestational phases contributes to risks of low birth weight. Hum Reprod (2003) 1.57
Identification and characterization of a TFIID-like multiprotein complex from Saccharomyces cerevisiae. Proc Natl Acad Sci U S A (1995) 1.56
Stimulation of aggrecan synthesis in cartilage explants by cyclic loading is localized to regions of high interstitial fluid flow. Arch Biochem Biophys (1999) 1.56
Common promoter polymorphism in monocyte differentiation antigen CD14 is associated with serum triglyceride levels and body mass index in non-diabetic individuals. Diabet Med (2006) 1.52
Tumour-infiltrating CD8+ lymphocytes as an independent predictive factor for pathological complete response to primary systemic therapy in breast cancer. Br J Cancer (2013) 1.50
Behavioral, attitudinal, and physiologic characteristics of smoking and nonsmoking asbestos-exposed shipyard workers. J Occup Med (1983) 1.50
Requirement for a functional interaction between mediator components Med6 and Srb4 in RNA polymerase II transcription. Mol Cell Biol (1998) 1.48
An extended medial to lateral approach to mobilize the splenic flexure during laparoscopic low anterior resection. Colorectal Dis (2013) 1.47
Difference in direct charge-parity violation between charged and neutral B meson decays. Nature (2008) 1.46
Interaliasing distance of the flow convergence surface for determining mitral regurgitant volume: a validation study in a chronic animal model. J Am Coll Cardiol (2001) 1.46
Genetic analyses of Schizosaccharomyces pombe dna2(+) reveal that dna2 plays an essential role in Okazaki fragment metabolism. Genetics (2000) 1.45
Activator-specific requirement of yeast mediator proteins for RNA polymerase II transcriptional activation. Mol Cell Biol (1999) 1.44
Identification of a novel activation-inducible protein of the tumor necrosis factor receptor superfamily and its ligand. J Biol Chem (1999) 1.41
High tumour islet macrophage infiltration correlates with improved patient survival but not with EGFR mutations, gene copy number or protein expression in resected non-small cell lung cancer. Br J Cancer (2008) 1.41
Chemical composition and source apportionment of PM2.5 particles in the Sihwa area, Korea. J Air Waste Manag Assoc (2001) 1.39
Mechanical compression alters proteoglycan deposition and matrix deformation around individual cells in cartilage explants. J Cell Sci (1998) 1.36
Expansion of CD133(+) colon cancer cultures retaining stem cell properties to enable cancer stem cell target discovery. Br J Cancer (2010) 1.35
Alternative anthropometric indicators of mortality. Am J Clin Nutr (1985) 1.33
Polarized secretion of CXC chemokines by human intestinal epithelial cells in response to Bacteroides fragilis enterotoxin: NF-kappa B plays a major role in the regulation of IL-8 expression. Clin Exp Immunol (2001) 1.32
Cyclophilin a binds to peroxiredoxins and activates its peroxidase activity. J Biol Chem (2001) 1.32
A case of spontaneous pneumomediastinum and pneumopericardium in a young adult. Korean J Intern Med (2001) 1.30
Precision top-quark mass measurement at CDF. Phys Rev Lett (2012) 1.30
Hybrid natural orifice transluminal endoscopic surgery: endoscopic full-thickness resection of early gastric cancer and laparoscopic regional lymph node dissection--14 human cases. Endoscopy (2010) 1.27
Ultrafast collinear scattering and carrier multiplication in graphene. Nat Commun (2013) 1.24
Measurement of the cross section for prompt isolated diphoton production using the full CDF run II data sample. Phys Rev Lett (2013) 1.22
Nuclear localization and phosphorylation of three 25-kilodalton rat stress proteins. Mol Cell Biol (1984) 1.21
Gender differences in injuries among rural youth. Inj Prev (1995) 1.21
Neurophysiological effects of stimulation through electrodes in the human subthalamic nucleus. Brain (1999) 1.21
Decomposition of the difference between two rates with hierarchical factors. Demography (1984) 1.20
Toward an acoustic typology of motor speech disorders. Clin Linguist Phon (2003) 1.19
Relative specificities in binding of Watson-Crick base pairs by third strand residues in a DNA pyrimidine triplex motif. Nucleic Acids Res (1993) 1.18
Pharmacokinetics, safety, and monotherapy antiviral activity of GSK1265744, an HIV integrase strand transfer inhibitor. HIV Clin Trials (2013) 1.18
The incidence, risk factors and prognostic implications of venous thromboembolism in patients with gastric cancer. J Thromb Haemost (2009) 1.18
Measurement of the differential branching fraction and forward-backward asymmetry for B --> K(*)l+l-. Phys Rev Lett (2009) 1.17
Sex-lethal, master and slave: a hierarchy of germ-line sex determination in Drosophila. Development (1993) 1.17
Hip Osteoarthritis MRI Scoring System (HOAMS): reliability and associations with radiographic and clinical findings. Osteoarthritis Cartilage (2011) 1.17
Drosophila Mediator complex is broadly utilized by diverse gene-specific transcription factors at different types of core promoters. Mol Cell Biol (2001) 1.16
Femoroacetabular cam-type impingement: diagnostic sensitivity and specificity of radiographic views compared to radial MRI. Eur J Radiol (2010) 1.16
The 20 bp, directly repeated DNA sequence of broad host range plasmid R1162 exerts incompatibility in vivo and inhibits R1162 DNA replication in vitro. Mol Gen Genet (1987) 1.15
Neurofibromatosis of the colon and rectum combined with other manifestations of von Recklinghausen's disease: report of a case. Dis Colon Rectum (1998) 1.14
The impact of the Mississippi Improved Child Health Project on prenatal care and low birthweight. Am J Public Health (1986) 1.14
Characteristics of ion components and trace elements of fine particles at Gosan, Korea in spring time from 2001 to 2002. Environ Monit Assess (2004) 1.13
A new antibiotic CJ-17,665 from Aspergillus ochraceus. J Antibiot (Tokyo) (2001) 1.13
Bernese periacetabular osteotomy in males: is there an increased risk of femoroacetabular impingement (FAI) after Bernese periacetabular osteotomy? Clin Orthop Relat Res (2011) 1.12
Clinical manifestations of foot-and-mouth disease during the 2010/2011 epidemic in the Republic of Korea. Transbound Emerg Dis (2012) 1.11
Comparative study of angiostatic and anti-invasive gene expressions as prognostic factors in gastric cancer. Int J Oncol (2001) 1.11
Sepsis affects most routine and cell population data (CPD) obtained using the Sysmex XN-2000 blood cell analyzer: neutrophil-related CPD NE-SFL and NE-WY provide useful information for detecting sepsis. Int J Lab Hematol (2014) 1.11
Clinicopathological characteristics of gastric carcinoma in young patients. Langenbecks Arch Surg (2003) 1.11
On the mechanism of pyridoxine responsive homocystinuria. II. Properties of normal and mutant cystathionine beta-synthase from cultured fibroblasts. Proc Natl Acad Sci U S A (1974) 1.09
Identification of the genes encoding enzymes involved in the early biosynthetic pathway of pteridines in Synechocystis sp. PCC 6803. FEMS Microbiol Lett (1999) 1.09
Evidence for a particle produced in association with weak bosons and decaying to a bottom-antibottom quark pair in higgs boson searches at the tevatron. Phys Rev Lett (2012) 1.08
Antimicrobial characteristics of chitosans against food spoilage microorganisms in liquid media and mayonnaise. Biosci Biotechnol Biochem (2001) 1.08
Genome-wide association study in a Chinese population identifies a susceptibility locus for type 2 diabetes at 7q32 near PAX4. Diabetologia (2013) 1.07
Iron status and its association with pregnancy outcome in Korean pregnant women. Eur J Clin Nutr (2006) 1.07
The association between malnutrition and diarrhoea in rural Bangladesh. Int J Epidemiol (1987) 1.06
Angiogenic activity of pyruvic acid in in vivo and in vitro angiogenesis models. Cancer Res (2001) 1.06
Altered aggrecan synthesis correlates with cell and nucleus structure in statically compressed cartilage. J Cell Sci (1996) 1.06
Clinicopathologic features of mucinous gastric carcinoma. Dig Surg (2002) 1.06
Complete nucleotide sequence and functional analysis of the genes for 2-aminophenol metabolism from Pseudomonas sp. AP-3. Arch Microbiol (2000) 1.06
Precise measurement of the W-boson mass with the CDF II detector. Phys Rev Lett (2012) 1.06
Yeast RNA polymerase II holoenzyme. Methods Enzymol (1996) 1.06
Phase II trial of everolimus for the treatment of nonclear-cell renal cell carcinoma. Ann Oncol (2012) 1.05
Aberrant expression of cyclin D1 is associated with poor prognosis in early stage cervical cancer of the uterus. Gynecol Oncol (2001) 1.05
Requirement of RBP9, a Drosophila Hu homolog, for regulation of cystocyte differentiation and oocyte determination during oogenesis. Mol Cell Biol (1999) 1.05
Purification and characterization of UDP-glucose:tetrahydrobiopterin glucosyltransferase from Synechococcus sp. PCC 7942. Biochim Biophys Acta (2000) 1.04
Endoscopic submucosal dissection with sentinel node navigation surgery for early gastric cancer. Endoscopy (2012) 1.04
The effectiveness of smoking cessation advice given during routine medical care: physicians can make a difference. Am J Prev Med (1988) 1.04
Declines in nonwhite and white neonatal mortality in Mississippi, 1975-80. Public Health Rep (1985) 1.04
Prevalence of non-tuberculous mycobacteria in a hospital environment. J Hosp Infect (2006) 1.04
Hepatosplenic tuberculosis mimicking disseminated candidiasis in patients with acute leukemia. Int J Hematol (2001) 1.03
Inhibition of tyrosinase by green tea components. Life Sci (1999) 1.03
Diffusion-weighted MRI in cystic or necrotic intracranial lesions. Neuroradiology (2000) 1.02
Radial dGEMRIC in developmental dysplasia of the hip and in femoroacetabular impingement: preliminary results. Osteoarthritis Cartilage (2010) 1.02